Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Quality Index
Medprin Regenerative Medical Technologies Co. Ltd. cash flow quality index. Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Quality Index of 1.48x as of December 2024. Operating cash flow of CN¥116.38 Million exceeds net income of CN¥78.85 Million, indicating high earnings quality where cash backs reported profits. See 301033 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Cash flow quality index of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. Historical Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 301033 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Quality Index by Year (2019–2024)
Medprin Regenerative Medical Technologies Co. Ltd. cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Medprin Regenerative Medical Technologies Co. Ltd.. For the full cash flow conversion analysis, see Medprin Regenerative Medical Technologie cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.48x | CN¥116.38 Million | CN¥78.85 Million | ▼ -44.0% |
| 2023 | 2.63x | CN¥107.69 Million | CN¥40.88 Million | ▲ +95.7% |
| 2022 | 1.35x | CN¥48.31 Million | CN¥35.89 Million | ▼ -9.5% |
| 2021 | 1.49x | CN¥66.51 Million | CN¥44.73 Million | ▲ +62.1% |
| 2020 | 0.92x | CN¥33.91 Million | CN¥36.97 Million | ▼ -18.8% |
| 2019 | 1.13x | CN¥31.27 Million | CN¥27.68 Million | — |